data_1fd8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fd8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 155.94 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 153.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -98.41 159.9 14.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mt -82.84 120.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -110.3 159.51 17.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.42 110.33 22.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -97.32 151.19 20.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -132.29 134.94 45.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.49 150.19 50.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.163 1.385 . . . . 0.0 109.038 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.76 105.39 13.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 170.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.48 144.96 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.871 0.868 . . . . 0.0 110.747 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.56 66.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.367 0.603 . . . . 0.0 111.824 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.3 mtm -83.5 67.86 9.54 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.89 -1.131 . . . . 0.0 112.437 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -93.8 -31.31 14.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.1 p -85.26 145.19 27.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.952 0.796 . . . . 0.0 110.711 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 64.51 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.262 -0.899 . . . . 0.0 110.905 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -59.45 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.0 p -50.39 -41.19 51.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.245 1.018 . . . . 0.0 113.09 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 p -49.47 -51.93 32.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.056 0.844 . . . . 0.0 110.278 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.23 98.77 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.019 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -48.27 74.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.494 0.647 . . . . 0.0 111.617 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.42 -51.77 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -52.0 -45.95 64.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -56.81 -44.19 81.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.58 -0.7 . . . . 0.0 112.524 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -59.08 -39.19 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.349 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.35 -42.38 95.62 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -52.45 -28.77 21.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.86 -34.89 44.63 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.329 0.968 . . . . 0.0 111.391 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.44 -16.75 47.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.397 0.679 . . . . 0.0 112.026 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -36.24 -57.44 1.09 Allowed Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.42 56.32 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.922 1.748 . . . . 0.0 111.801 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -176.67 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.716 2.406 . . . . 0.0 107.254 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.38 147.33 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.387 0.675 . . . . 0.0 110.128 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.1 t -93.45 -48.07 6.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.377 0.671 . . . . 0.0 110.473 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -151.77 156.13 39.64 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -136.56 153.95 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.134 1.374 . . . . 0.0 107.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.71 145.25 24.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 161.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 tt -135.4 133.4 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 125.869 1.667 . . . . 0.0 108.814 -168.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.3 t -137.69 106.36 5.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.102 0.865 . . . . 0.0 110.076 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.15 -53.96 45.12 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.999 0.52 . . . . 0.0 110.177 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -41.42 -56.88 2.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.466 0.706 . . . . 0.0 111.74 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.99 21.35 9.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.574 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 34.82 50.5 0.45 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.884 2.074 . . . . 0.0 112.653 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.88 159.53 42.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.354 0.597 . . . . 0.0 111.647 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -143.59 118.88 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -110.92 130.88 55.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.6 129.84 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -109.3 104.31 13.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -157.22 171.54 20.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.22 1.01 . . . . 0.0 111.842 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.27 9.6 p -79.87 -40.88 27.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 131.523 3.929 . . . . 0.0 109.395 172.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.34 138.6 88.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.155 0.982 . . . . 0.0 111.611 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.57 146.05 60.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.571 2.181 . . . . 0.0 112.621 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -33.39 -62.48 0.28 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.49 2.716 . . . . 0.0 112.835 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -49.59 -44.86 47.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.523 1.929 . . . . 0.0 112.079 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 mm -67.52 -47.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.338 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -49.33 -52.55 27.25 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.114 0.87 . . . . 0.0 111.934 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -63.33 1.18 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -43.89 -48.08 8.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.272 1.029 . . . . 0.0 112.211 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.03 -70.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 123.421 0.688 . . . . 0.0 109.279 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -54.0 -33.45 57.14 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -43.64 -38.43 3.06 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.423 1.489 . . . . 0.0 111.657 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.8 p -67.09 -21.21 65.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.11 -52.64 0.58 Allowed Glycine 0 C--N 1.339 0.738 0 CA-C-N 118.676 0.671 . . . . 0.0 111.762 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -63.39 163.91 9.98 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 117.703 0.751 . . . . 0.0 111.988 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.04 152.18 23.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.06 120.27 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 171.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -74.65 -60.39 2.3 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.279 -0.888 . . . . 0.0 109.336 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -158.63 179.8 8.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.123 1.369 . . . . 0.0 107.941 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.41 -177.7 40.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.32 173.58 16.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.563 1.545 . . . . 0.0 108.977 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.605 1.162 . . . . 0.0 110.05 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 C--O 1.259 1.579 0 C-N-CA 128.249 2.619 . . . . 0.0 107.115 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 155.94 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 153.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -98.41 159.9 14.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mt -82.84 120.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -110.3 159.51 17.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.42 110.33 22.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 92.5 m-85 -97.32 151.19 20.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -132.29 134.94 45.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 7' ' ' TYR . 18.4 m-85 -129.49 150.19 50.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.163 1.385 . . . . 0.0 109.038 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.76 105.39 13.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 170.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.48 144.96 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.871 0.868 . . . . 0.0 110.747 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.56 66.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.367 0.603 . . . . 0.0 111.824 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.3 mtm -83.5 67.86 9.54 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.89 -1.131 . . . . 0.0 112.437 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -93.8 -31.31 14.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.1 p -85.26 145.19 27.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.952 0.796 . . . . 0.0 110.711 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 64.51 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.262 -0.899 . . . . 0.0 110.905 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -59.45 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.0 p -50.39 -41.19 51.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.245 1.018 . . . . 0.0 113.09 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 p -49.47 -51.93 32.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.056 0.844 . . . . 0.0 110.278 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.23 98.77 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.019 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -48.27 74.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.494 0.647 . . . . 0.0 111.617 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.42 -51.77 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -52.0 -45.95 64.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -56.81 -44.19 81.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.58 -0.7 . . . . 0.0 112.524 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -59.08 -39.19 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.349 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.35 -42.38 95.62 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -52.45 -28.77 21.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.86 -34.89 44.63 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.329 0.968 . . . . 0.0 111.391 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.44 -16.75 47.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.397 0.679 . . . . 0.0 112.026 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -36.24 -57.44 1.09 Allowed Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.42 56.32 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.922 1.748 . . . . 0.0 111.801 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -176.67 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.716 2.406 . . . . 0.0 107.254 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.38 147.33 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.387 0.675 . . . . 0.0 110.128 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.1 t -93.45 -48.07 6.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.377 0.671 . . . . 0.0 110.473 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -151.77 156.13 39.64 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -136.56 153.95 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.134 1.374 . . . . 0.0 107.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.71 145.25 24.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 161.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 tt -135.4 133.4 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 125.869 1.667 . . . . 0.0 108.814 -168.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.3 t -137.69 106.36 5.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.102 0.865 . . . . 0.0 110.076 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.15 -53.96 45.12 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.999 0.52 . . . . 0.0 110.177 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -41.42 -56.88 2.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.466 0.706 . . . . 0.0 111.74 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.99 21.35 9.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.574 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 34.82 50.5 0.45 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.884 2.074 . . . . 0.0 112.653 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.88 159.53 42.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.354 0.597 . . . . 0.0 111.647 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -143.59 118.88 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -110.92 130.88 55.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.6 129.84 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -109.3 104.31 13.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -157.22 171.54 20.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.22 1.01 . . . . 0.0 111.842 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.27 9.6 p -79.87 -40.88 27.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 131.523 3.929 . . . . 0.0 109.395 172.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.34 138.6 88.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.155 0.982 . . . . 0.0 111.611 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.57 146.05 60.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.571 2.181 . . . . 0.0 112.621 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -33.39 -62.48 0.28 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.49 2.716 . . . . 0.0 112.835 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -49.59 -44.86 47.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.523 1.929 . . . . 0.0 112.079 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 mm -67.52 -47.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.338 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 54' ' ' ASP . 16.2 mt -49.33 -52.55 27.25 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.114 0.87 . . . . 0.0 111.934 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -63.33 1.18 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -43.89 -48.08 8.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.272 1.029 . . . . 0.0 112.211 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.03 -70.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 123.421 0.688 . . . . 0.0 109.279 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -54.0 -33.45 57.14 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -43.64 -38.43 3.06 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.423 1.489 . . . . 0.0 111.657 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.8 p -67.09 -21.21 65.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.11 -52.64 0.58 Allowed Glycine 0 C--N 1.339 0.738 0 CA-C-N 118.676 0.671 . . . . 0.0 111.762 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -63.39 163.91 9.98 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 117.703 0.751 . . . . 0.0 111.988 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.04 152.18 23.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.06 120.27 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 171.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -74.65 -60.39 2.3 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.279 -0.888 . . . . 0.0 109.336 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -158.63 179.8 8.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.123 1.369 . . . . 0.0 107.941 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.41 -177.7 40.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.32 173.58 16.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.563 1.545 . . . . 0.0 108.977 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.605 1.162 . . . . 0.0 110.05 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 C--O 1.259 1.579 0 C-N-CA 128.249 2.619 . . . . 0.0 107.115 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 155.94 28.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 153.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -98.41 159.9 14.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.3 mt -82.84 120.58 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -110.3 159.51 17.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.42 110.33 22.24 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 92.5 m-85 -97.32 151.19 20.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 174.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -132.29 134.94 45.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 171.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 7' ' ' TYR . 18.4 m-85 -129.49 150.19 50.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.163 1.385 . . . . 0.0 109.038 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.76 105.39 13.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 170.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.48 144.96 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.871 0.868 . . . . 0.0 110.747 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.56 66.74 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.367 0.603 . . . . 0.0 111.824 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.3 mtm -83.5 67.86 9.54 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.89 -1.131 . . . . 0.0 112.437 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -93.8 -31.31 14.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.1 p -85.26 145.19 27.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.952 0.796 . . . . 0.0 110.711 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 m -74.32 64.51 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.262 -0.899 . . . . 0.0 110.905 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -157.86 -59.45 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.0 p -50.39 -41.19 51.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.245 1.018 . . . . 0.0 113.09 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.8 p -49.47 -51.93 32.6 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.056 0.844 . . . . 0.0 110.278 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.23 98.77 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.019 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -48.27 74.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.494 0.647 . . . . 0.0 111.617 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.42 -51.77 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -52.0 -45.95 64.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -56.81 -44.19 81.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.58 -0.7 . . . . 0.0 112.524 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.2 t -59.08 -39.19 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.349 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.35 -42.38 95.62 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -52.45 -28.77 21.46 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.86 -34.89 44.63 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.329 0.968 . . . . 0.0 111.391 173.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.44 -16.75 47.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.397 0.679 . . . . 0.0 112.026 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -36.24 -57.44 1.09 Allowed Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.42 56.32 4.46 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.922 1.748 . . . . 0.0 111.801 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -176.67 -50.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.716 2.406 . . . . 0.0 107.254 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.38 147.33 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.387 0.675 . . . . 0.0 110.128 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.1 t -93.45 -48.07 6.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.377 0.671 . . . . 0.0 110.473 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -151.77 156.13 39.64 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 pp -136.56 153.95 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.134 1.374 . . . . 0.0 107.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.71 145.25 24.16 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 161.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 tt -135.4 133.4 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 125.869 1.667 . . . . 0.0 108.814 -168.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.3 t -137.69 106.36 5.88 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.102 0.865 . . . . 0.0 110.076 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.15 -53.96 45.12 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.999 0.52 . . . . 0.0 110.177 170.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -41.42 -56.88 2.36 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.466 0.706 . . . . 0.0 111.74 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -96.99 21.35 9.83 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.574 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 34.82 50.5 0.45 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 126.884 2.074 . . . . 0.0 112.653 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -140.88 159.53 42.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.354 0.597 . . . . 0.0 111.647 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -143.59 118.88 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -168.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -110.92 130.88 55.45 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.7 t -136.6 129.84 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -109.3 104.31 13.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t -157.22 171.54 20.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.22 1.01 . . . . 0.0 111.842 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . 0.27 9.6 p -79.87 -40.88 27.41 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 131.523 3.929 . . . . 0.0 109.395 172.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.34 138.6 88.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.155 0.982 . . . . 0.0 111.611 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.57 146.05 60.17 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.571 2.181 . . . . 0.0 112.621 -172.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -33.39 -62.48 0.28 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.49 2.716 . . . . 0.0 112.835 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 57' ' ' LEU . 2.1 m-20 -49.59 -44.86 47.28 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 126.523 1.929 . . . . 0.0 112.079 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 mm -67.52 -47.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.338 -177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 54' ' ' ASP . 16.2 mt -49.33 -52.55 27.25 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.114 0.87 . . . . 0.0 111.934 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -63.33 1.18 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -43.89 -48.08 8.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.272 1.029 . . . . 0.0 112.211 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.03 -70.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 C-N-CA 123.421 0.688 . . . . 0.0 109.279 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -54.0 -33.45 57.14 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -43.64 -38.43 3.06 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 125.423 1.489 . . . . 0.0 111.657 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 50.8 p -67.09 -21.21 65.88 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.11 -52.64 0.58 Allowed Glycine 0 C--N 1.339 0.738 0 CA-C-N 118.676 0.671 . . . . 0.0 111.762 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -63.39 163.91 9.98 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 117.703 0.751 . . . . 0.0 111.988 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -85.04 152.18 23.61 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.06 120.27 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 171.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -74.65 -60.39 2.3 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.279 -0.888 . . . . 0.0 109.336 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -158.63 179.8 8.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.123 1.369 . . . . 0.0 107.941 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.41 -177.7 40.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.32 173.58 16.72 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.563 1.545 . . . . 0.0 108.977 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -120.19 150.46 40.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.605 1.162 . . . . 0.0 110.05 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 C--O 1.259 1.579 0 C-N-CA 128.249 2.619 . . . . 0.0 107.115 -173.309 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_